Potentiating effect of imiquimod in the treatment of verrucae vulgares in immunocompromised patients.
Weisshaar
E
E
Gollnick
H
H
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D003521:Cyclopropanes / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D000077271:Imiquimod; D016867:Immunocompromised Host; D008297:Male; D009824:Ointments; D014860:Warts / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D003521:Cyclopropanes; D009824:Ointments; C029402:diphenylcyclopropenone; D000077271:Imiquimod